您的位置: 首页 > 农业专利 > 详情页

PROCEDE DE TRAITEMENT OU D'AMELIORATION DE TROUBLES METABOLIQUES A L'AIDE D'AGONISTES DU RECEPTEUR DU GLP-1 CONJUGUES A DES ANTAGONISTES DU RECEPTEUR DU PEPTIDE INHIBITEUR GASTRIQUE (GIPR)
专利权人:
AMGEN INC.
发明人:
CHENG, YUAN,NETIROJJANAKUL, CHAWITA,HOLDER, JERRY RYAN,WU, BIN,FALSEY, JAMES R.,HERBERICH, BRADLEY J.,SHAM, KELVIN,MIRANDA, LESLIE P.,LU, SHU-CHEN,VENIANT-ELLISON, MURIELLE M.,STANISLAUS, SHANAKA,YIE,
申请号:
CA3049023
公开号:
CA3049023A1
申请日:
2018.01.16
申请国别(地区):
CA
年份:
2018
代理人:
摘要:
Methods of treating metabolic diseases and disorders using a composition comprising an antigen binding protein specific for the GIPR polypeptide conjugated to a GLP-1 receptor agonist are provided. In various embodiments the metabolic disease or disorder is type 2 diabetes, obesity, dyslipidemia, elevated glucose levels, elevated insulin levels and diabetic nephropathy. In certain embodiments the composition comprises an antibody or functional fragment thereof comprising a cysteine at one or more conjugation site(s) wherein the GLP-1 receptor agonist is conjugated to the antibody or functional fragment thereof through the side-chain of the cysteine residue.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充